The global market for Human Macrophage Colony Stimulating Factor was valued at US$ 157 million in the year 2024 and is projected to reach a revised size of US$ 269 million by 2031, growing at a CAGR of 8.5% during the forecast period.

Human Macrophage Colony Stimulating Factor Market

Macrophage colony stimulating factor (M-CSF) is a potent hematopoietic factor produced by a variety of cells, including lymphocytes, monocytes, fibroblasts, endothelial cells, myoblasts, and osteoblasts. It is a key regulator of proliferation, differentiation, and survival of blood monocytes, tissue macrophages, and their respective progenitors. M-CSF has been shown to play an important role in regulating skin thickness and fertility. M-CSF is used clinically to treat infections, malignancies, and atherosclerosis. It helps hematopoietic recovery after bone marrow transplantation.

North American market for Human Macrophage Colony Stimulating Factor is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Human Macrophage Colony Stimulating Factor is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Human Macrophage Colony Stimulating Factor include Novartis, Amgen, Betta Pharmaceuticals, Thermo Fisher Scientific Inc., Eli Lilly and Company, Bio-Techne, Merck, Yeasen, Sino Biological, Miltenyi Biotec, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Human Macrophage Colony Stimulating Factor, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Macrophage Colony Stimulating Factor.

The Human Macrophage Colony Stimulating Factor market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Macrophage Colony Stimulating Factor market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Human Macrophage Colony Stimulating Factor manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Human Macrophage Colony Stimulating Factor Market Report

Report Metric	Details
Report Name	Human Macrophage Colony Stimulating Factor Market
Accounted market size in year	US$ 157 million
Forecasted market size in 2031	US$ 269 million
CAGR	8.5%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Purity＞95% Purity≤95%
Segment by Application	Medical and Biological Laboratories University Laboratories Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Novartis, Amgen, Betta Pharmaceuticals, Thermo Fisher Scientific Inc., Eli Lilly and Company, Bio-Techne, Merck, Yeasen, Sino Biological, Miltenyi Biotec, Proteintech, BioLegend
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Human Macrophage Colony Stimulating Factor manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Human Macrophage Colony Stimulating Factor in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Human Macrophage Colony Stimulating Factor Market growing?

Ans: The Human Macrophage Colony Stimulating Factor Market witnessing a CAGR of 8.5% during the forecast period 2025-2031.

What is the Human Macrophage Colony Stimulating Factor Market size in 2031?

Ans: The Human Macrophage Colony Stimulating Factor Market size in 2031 will be US$ 269 million.

Who are the main players in the Human Macrophage Colony Stimulating Factor Market report?

Ans: The main players in the Human Macrophage Colony Stimulating Factor Market are Novartis, Amgen, Betta Pharmaceuticals, Thermo Fisher Scientific Inc., Eli Lilly and Company, Bio-Techne, Merck, Yeasen, Sino Biological, Miltenyi Biotec, Proteintech, BioLegend

What are the Application segmentation covered in the Human Macrophage Colony Stimulating Factor Market report?

Ans: The Applications covered in the Human Macrophage Colony Stimulating Factor Market report are Medical and Biological Laboratories, University Laboratories, Others

What are the Type segmentation covered in the Human Macrophage Colony Stimulating Factor Market report?

Ans: The Types covered in the Human Macrophage Colony Stimulating Factor Market report are Purity＞95%, Purity≤95%

1 Human Macrophage Colony Stimulating Factor Market Overview

1.1 Product Definition

1.2 Human Macrophage Colony Stimulating Factor by Type

1.2.1 Global Human Macrophage Colony Stimulating Factor Market Value Comparison by Type (2024 VS 2031)

1.2.2 Purity＞95%

1.2.3 Purity≤95%

1.3 Human Macrophage Colony Stimulating Factor by Application

1.3.1 Global Human Macrophage Colony Stimulating Factor Market Value by Application (2024 VS 2031)

1.3.2 Medical and Biological Laboratories

1.3.3 University Laboratories

1.3.4 Others

1.4 Global Human Macrophage Colony Stimulating Factor Market Size Estimates and Forecasts

1.4.1 Global Human Macrophage Colony Stimulating Factor Revenue 2020-2031

1.4.2 Global Human Macrophage Colony Stimulating Factor Sales 2020-2031

1.4.3 Global Human Macrophage Colony Stimulating Factor Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Human Macrophage Colony Stimulating Factor Market Competition by Manufacturers

2.1 Global Human Macrophage Colony Stimulating Factor Sales Market Share by Manufacturers (2020-2025)

2.2 Global Human Macrophage Colony Stimulating Factor Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Human Macrophage Colony Stimulating Factor Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Human Macrophage Colony Stimulating Factor, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Human Macrophage Colony Stimulating Factor, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Human Macrophage Colony Stimulating Factor, Product Type & Application

2.7 Global Key Manufacturers of Human Macrophage Colony Stimulating Factor, Date of Enter into This Industry

2.8 Global Human Macrophage Colony Stimulating Factor Market Competitive Situation and Trends

2.8.1 Global Human Macrophage Colony Stimulating Factor Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Human Macrophage Colony Stimulating Factor Players Market Share by Revenue

2.8.3 Global Human Macrophage Colony Stimulating Factor Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Human Macrophage Colony Stimulating Factor Market Scenario by Region

3.1 Global Human Macrophage Colony Stimulating Factor Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Human Macrophage Colony Stimulating Factor Sales by Region: 2020-2031

3.2.1 Global Human Macrophage Colony Stimulating Factor Sales by Region: 2020-2025

3.2.2 Global Human Macrophage Colony Stimulating Factor Sales by Region: 2026-2031

3.3 Global Human Macrophage Colony Stimulating Factor Revenue by Region: 2020-2031

3.3.1 Global Human Macrophage Colony Stimulating Factor Revenue by Region: 2020-2025

3.3.2 Global Human Macrophage Colony Stimulating Factor Revenue by Region: 2026-2031

3.4 North America Human Macrophage Colony Stimulating Factor Market Facts & Figures by Country

3.4.1 North America Human Macrophage Colony Stimulating Factor Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Human Macrophage Colony Stimulating Factor Sales by Country (2020-2031)

3.4.3 North America Human Macrophage Colony Stimulating Factor Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Human Macrophage Colony Stimulating Factor Market Facts & Figures by Country

3.5.1 Europe Human Macrophage Colony Stimulating Factor Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Human Macrophage Colony Stimulating Factor Sales by Country (2020-2031)

3.5.3 Europe Human Macrophage Colony Stimulating Factor Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Human Macrophage Colony Stimulating Factor Market Facts & Figures by Region

3.6.1 Asia Pacific Human Macrophage Colony Stimulating Factor Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Human Macrophage Colony Stimulating Factor Sales by Region (2020-2031)

3.6.3 Asia Pacific Human Macrophage Colony Stimulating Factor Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Human Macrophage Colony Stimulating Factor Market Facts & Figures by Country

3.7.1 Latin America Human Macrophage Colony Stimulating Factor Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Human Macrophage Colony Stimulating Factor Sales by Country (2020-2031)

3.7.3 Latin America Human Macrophage Colony Stimulating Factor Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Human Macrophage Colony Stimulating Factor Market Facts & Figures by Country

3.8.1 Middle East and Africa Human Macrophage Colony Stimulating Factor Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Human Macrophage Colony Stimulating Factor Sales by Country (2020-2031)

3.8.3 Middle East and Africa Human Macrophage Colony Stimulating Factor Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Human Macrophage Colony Stimulating Factor Sales by Type (2020-2031)

4.1.1 Global Human Macrophage Colony Stimulating Factor Sales by Type (2020-2025)

4.1.2 Global Human Macrophage Colony Stimulating Factor Sales by Type (2026-2031)

4.1.3 Global Human Macrophage Colony Stimulating Factor Sales Market Share by Type (2020-2031)

4.2 Global Human Macrophage Colony Stimulating Factor Revenue by Type (2020-2031)

4.2.1 Global Human Macrophage Colony Stimulating Factor Revenue by Type (2020-2025)

4.2.2 Global Human Macrophage Colony Stimulating Factor Revenue by Type (2026-2031)

4.2.3 Global Human Macrophage Colony Stimulating Factor Revenue Market Share by Type (2020-2031)

4.3 Global Human Macrophage Colony Stimulating Factor Price by Type (2020-2031)

5 Segment by Application

5.1 Global Human Macrophage Colony Stimulating Factor Sales by Application (2020-2031)

5.1.1 Global Human Macrophage Colony Stimulating Factor Sales by Application (2020-2025)

5.1.2 Global Human Macrophage Colony Stimulating Factor Sales by Application (2026-2031)

5.1.3 Global Human Macrophage Colony Stimulating Factor Sales Market Share by Application (2020-2031)

5.2 Global Human Macrophage Colony Stimulating Factor Revenue by Application (2020-2031)

5.2.1 Global Human Macrophage Colony Stimulating Factor Revenue by Application (2020-2025)

5.2.2 Global Human Macrophage Colony Stimulating Factor Revenue by Application (2026-2031)

5.2.3 Global Human Macrophage Colony Stimulating Factor Revenue Market Share by Application (2020-2031)

5.3 Global Human Macrophage Colony Stimulating Factor Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Novartis

6.1.1 Novartis Company Information

6.1.2 Novartis Description and Business Overview

6.1.3 Novartis Human Macrophage Colony Stimulating Factor Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Novartis Human Macrophage Colony Stimulating Factor Product Portfolio

6.1.5 Novartis Recent Developments/Updates

6.2 Amgen

6.2.1 Amgen Company Information

6.2.2 Amgen Description and Business Overview

6.2.3 Amgen Human Macrophage Colony Stimulating Factor Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Amgen Human Macrophage Colony Stimulating Factor Product Portfolio

6.2.5 Amgen Recent Developments/Updates

6.3 Betta Pharmaceuticals

6.3.1 Betta Pharmaceuticals Company Information

6.3.2 Betta Pharmaceuticals Description and Business Overview

6.3.3 Betta Pharmaceuticals Human Macrophage Colony Stimulating Factor Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Betta Pharmaceuticals Human Macrophage Colony Stimulating Factor Product Portfolio

6.3.5 Betta Pharmaceuticals Recent Developments/Updates

6.4 Thermo Fisher Scientific Inc.

6.4.1 Thermo Fisher Scientific Inc. Company Information

6.4.2 Thermo Fisher Scientific Inc. Description and Business Overview

6.4.3 Thermo Fisher Scientific Inc. Human Macrophage Colony Stimulating Factor Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Thermo Fisher Scientific Inc. Human Macrophage Colony Stimulating Factor Product Portfolio

6.4.5 Thermo Fisher Scientific Inc. Recent Developments/Updates

6.5 Eli Lilly and Company

6.5.1 Eli Lilly and Company Company Information

6.5.2 Eli Lilly and Company Description and Business Overview

6.5.3 Eli Lilly and Company Human Macrophage Colony Stimulating Factor Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Eli Lilly and Company Human Macrophage Colony Stimulating Factor Product Portfolio

6.5.5 Eli Lilly and Company Recent Developments/Updates

6.6 Bio-Techne

6.6.1 Bio-Techne Company Information

6.6.2 Bio-Techne Description and Business Overview

6.6.3 Bio-Techne Human Macrophage Colony Stimulating Factor Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Bio-Techne Human Macrophage Colony Stimulating Factor Product Portfolio

6.6.5 Bio-Techne Recent Developments/Updates

6.7 Merck

6.7.1 Merck Company Information

6.7.2 Merck Description and Business Overview

6.7.3 Merck Human Macrophage Colony Stimulating Factor Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Merck Human Macrophage Colony Stimulating Factor Product Portfolio

6.7.5 Merck Recent Developments/Updates

6.8 Yeasen

6.8.1 Yeasen Company Information

6.8.2 Yeasen Description and Business Overview

6.8.3 Yeasen Human Macrophage Colony Stimulating Factor Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Yeasen Human Macrophage Colony Stimulating Factor Product Portfolio

6.8.5 Yeasen Recent Developments/Updates

6.9 Sino Biological

6.9.1 Sino Biological Company Information

6.9.2 Sino Biological Description and Business Overview

6.9.3 Sino Biological Human Macrophage Colony Stimulating Factor Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Sino Biological Human Macrophage Colony Stimulating Factor Product Portfolio

6.9.5 Sino Biological Recent Developments/Updates

6.10 Miltenyi Biotec

6.10.1 Miltenyi Biotec Company Information

6.10.2 Miltenyi Biotec Description and Business Overview

6.10.3 Miltenyi Biotec Human Macrophage Colony Stimulating Factor Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Miltenyi Biotec Human Macrophage Colony Stimulating Factor Product Portfolio

6.10.5 Miltenyi Biotec Recent Developments/Updates

6.11 Proteintech

6.11.1 Proteintech Company Information

6.11.2 Proteintech Description and Business Overview

6.11.3 Proteintech Human Macrophage Colony Stimulating Factor Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Proteintech Human Macrophage Colony Stimulating Factor Product Portfolio

6.11.5 Proteintech Recent Developments/Updates

6.12 BioLegend

6.12.1 BioLegend Company Information

6.12.2 BioLegend Description and Business Overview

6.12.3 BioLegend Human Macrophage Colony Stimulating Factor Sales, Revenue and Gross Margin (2020-2025)

6.12.4 BioLegend Human Macrophage Colony Stimulating Factor Product Portfolio

6.12.5 BioLegend Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Human Macrophage Colony Stimulating Factor Industry Chain Analysis

7.2 Human Macrophage Colony Stimulating Factor Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Human Macrophage Colony Stimulating Factor Production Mode & Process Analysis

7.4 Human Macrophage Colony Stimulating Factor Sales and Marketing

7.4.1 Human Macrophage Colony Stimulating Factor Sales Channels

7.4.2 Human Macrophage Colony Stimulating Factor Distributors

7.5 Human Macrophage Colony Stimulating Factor Customer Analysis

8 Human Macrophage Colony Stimulating Factor Market Dynamics

8.1 Human Macrophage Colony Stimulating Factor Industry Trends

8.2 Human Macrophage Colony Stimulating Factor Market Drivers

8.3 Human Macrophage Colony Stimulating Factor Market Challenges

8.4 Human Macrophage Colony Stimulating Factor Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Regulator

Novartis

Amgen Inc

Betta Pharmaceuticals

Thermo Fisher Scientific Inc

Eli Lilly and Company

List of Tables

Table 1. Global Human Macrophage Colony Stimulating Factor Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Human Macrophage Colony Stimulating Factor Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Human Macrophage Colony Stimulating Factor Market Competitive Situation by Manufacturers in 2024

Table 4. Global Human Macrophage Colony Stimulating Factor Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Human Macrophage Colony Stimulating Factor Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Human Macrophage Colony Stimulating Factor Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Human Macrophage Colony Stimulating Factor Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Human Macrophage Colony Stimulating Factor Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Human Macrophage Colony Stimulating Factor, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Human Macrophage Colony Stimulating Factor, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Human Macrophage Colony Stimulating Factor, Product Type & Application

Table 12. Global Key Manufacturers of Human Macrophage Colony Stimulating Factor, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Human Macrophage Colony Stimulating Factor by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Macrophage Colony Stimulating Factor as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Human Macrophage Colony Stimulating Factor Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Human Macrophage Colony Stimulating Factor Sales by Region (2020-2025) & (K Units)

Table 18. Global Human Macrophage Colony Stimulating Factor Sales Market Share by Region (2020-2025)

Table 19. Global Human Macrophage Colony Stimulating Factor Sales by Region (2026-2031) & (K Units)

Table 20. Global Human Macrophage Colony Stimulating Factor Sales Market Share by Region (2026-2031)

Table 21. Global Human Macrophage Colony Stimulating Factor Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Human Macrophage Colony Stimulating Factor Revenue Market Share by Region (2020-2025)

Table 23. Global Human Macrophage Colony Stimulating Factor Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Human Macrophage Colony Stimulating Factor Revenue Market Share by Region (2026-2031)

Table 25. North America Human Macrophage Colony Stimulating Factor Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Human Macrophage Colony Stimulating Factor Sales by Country (2020-2025) & (K Units)

Table 27. North America Human Macrophage Colony Stimulating Factor Sales by Country (2026-2031) & (K Units)

Table 28. North America Human Macrophage Colony Stimulating Factor Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Human Macrophage Colony Stimulating Factor Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Human Macrophage Colony Stimulating Factor Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Human Macrophage Colony Stimulating Factor Sales by Country (2020-2025) & (K Units)

Table 32. Europe Human Macrophage Colony Stimulating Factor Sales by Country (2026-2031) & (K Units)

Table 33. Europe Human Macrophage Colony Stimulating Factor Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Human Macrophage Colony Stimulating Factor Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Human Macrophage Colony Stimulating Factor Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Human Macrophage Colony Stimulating Factor Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Human Macrophage Colony Stimulating Factor Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Human Macrophage Colony Stimulating Factor Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Human Macrophage Colony Stimulating Factor Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Human Macrophage Colony Stimulating Factor Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Human Macrophage Colony Stimulating Factor Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Human Macrophage Colony Stimulating Factor Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Human Macrophage Colony Stimulating Factor Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Human Macrophage Colony Stimulating Factor Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Human Macrophage Colony Stimulating Factor Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Human Macrophage Colony Stimulating Factor Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Human Macrophage Colony Stimulating Factor Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Human Macrophage Colony Stimulating Factor Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Human Macrophage Colony Stimulating Factor Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Human Macrophage Colony Stimulating Factor Sales (K Units) by Type (2020-2025)

Table 51. Global Human Macrophage Colony Stimulating Factor Sales (K Units) by Type (2026-2031)

Table 52. Global Human Macrophage Colony Stimulating Factor Sales Market Share by Type (2020-2025)

Table 53. Global Human Macrophage Colony Stimulating Factor Sales Market Share by Type (2026-2031)

Table 54. Global Human Macrophage Colony Stimulating Factor Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Human Macrophage Colony Stimulating Factor Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Human Macrophage Colony Stimulating Factor Revenue Market Share by Type (2020-2025)

Table 57. Global Human Macrophage Colony Stimulating Factor Revenue Market Share by Type (2026-2031)

Table 58. Global Human Macrophage Colony Stimulating Factor Price (US$/Unit) by Type (2020-2025)

Table 59. Global Human Macrophage Colony Stimulating Factor Price (US$/Unit) by Type (2026-2031)

Table 60. Global Human Macrophage Colony Stimulating Factor Sales (K Units) by Application (2020-2025)

Table 61. Global Human Macrophage Colony Stimulating Factor Sales (K Units) by Application (2026-2031)

Table 62. Global Human Macrophage Colony Stimulating Factor Sales Market Share by Application (2020-2025)

Table 63. Global Human Macrophage Colony Stimulating Factor Sales Market Share by Application (2026-2031)

Table 64. Global Human Macrophage Colony Stimulating Factor Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Human Macrophage Colony Stimulating Factor Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Human Macrophage Colony Stimulating Factor Revenue Market Share by Application (2020-2025)

Table 67. Global Human Macrophage Colony Stimulating Factor Revenue Market Share by Application (2026-2031)

Table 68. Global Human Macrophage Colony Stimulating Factor Price (US$/Unit) by Application (2020-2025)

Table 69. Global Human Macrophage Colony Stimulating Factor Price (US$/Unit) by Application (2026-2031)

Table 70. Novartis Company Information

Table 71. Novartis Description and Business Overview

Table 72. Novartis Human Macrophage Colony Stimulating Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Novartis Human Macrophage Colony Stimulating Factor Product

Table 74. Novartis Recent Developments/Updates

Table 75. Amgen Company Information

Table 76. Amgen Description and Business Overview

Table 77. Amgen Human Macrophage Colony Stimulating Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Amgen Human Macrophage Colony Stimulating Factor Product

Table 79. Amgen Recent Developments/Updates

Table 80. Betta Pharmaceuticals Company Information

Table 81. Betta Pharmaceuticals Description and Business Overview

Table 82. Betta Pharmaceuticals Human Macrophage Colony Stimulating Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Betta Pharmaceuticals Human Macrophage Colony Stimulating Factor Product

Table 84. Betta Pharmaceuticals Recent Developments/Updates

Table 85. Thermo Fisher Scientific Inc. Company Information

Table 86. Thermo Fisher Scientific Inc. Description and Business Overview

Table 87. Thermo Fisher Scientific Inc. Human Macrophage Colony Stimulating Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Thermo Fisher Scientific Inc. Human Macrophage Colony Stimulating Factor Product

Table 89. Thermo Fisher Scientific Inc. Recent Developments/Updates

Table 90. Eli Lilly and Company Company Information

Table 91. Eli Lilly and Company Description and Business Overview

Table 92. Eli Lilly and Company Human Macrophage Colony Stimulating Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Eli Lilly and Company Human Macrophage Colony Stimulating Factor Product

Table 94. Eli Lilly and Company Recent Developments/Updates

Table 95. Bio-Techne Company Information

Table 96. Bio-Techne Description and Business Overview

Table 97. Bio-Techne Human Macrophage Colony Stimulating Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Bio-Techne Human Macrophage Colony Stimulating Factor Product

Table 99. Bio-Techne Recent Developments/Updates

Table 100. Merck Company Information

Table 101. Merck Description and Business Overview

Table 102. Merck Human Macrophage Colony Stimulating Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Merck Human Macrophage Colony Stimulating Factor Product

Table 104. Merck Recent Developments/Updates

Table 105. Yeasen Company Information

Table 106. Yeasen Description and Business Overview

Table 107. Yeasen Human Macrophage Colony Stimulating Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Yeasen Human Macrophage Colony Stimulating Factor Product

Table 109. Yeasen Recent Developments/Updates

Table 110. Sino Biological Company Information

Table 111. Sino Biological Description and Business Overview

Table 112. Sino Biological Human Macrophage Colony Stimulating Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Sino Biological Human Macrophage Colony Stimulating Factor Product

Table 114. Sino Biological Recent Developments/Updates

Table 115. Miltenyi Biotec Company Information

Table 116. Miltenyi Biotec Description and Business Overview

Table 117. Miltenyi Biotec Human Macrophage Colony Stimulating Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Miltenyi Biotec Human Macrophage Colony Stimulating Factor Product

Table 119. Miltenyi Biotec Recent Developments/Updates

Table 120. Proteintech Company Information

Table 121. Proteintech Description and Business Overview

Table 122. Proteintech Human Macrophage Colony Stimulating Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. Proteintech Human Macrophage Colony Stimulating Factor Product

Table 124. Proteintech Recent Developments/Updates

Table 125. BioLegend Company Information

Table 126. BioLegend Description and Business Overview

Table 127. BioLegend Human Macrophage Colony Stimulating Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 128. BioLegend Human Macrophage Colony Stimulating Factor Product

Table 129. BioLegend Recent Developments/Updates

Table 130. Key Raw Materials Lists

Table 131. Raw Materials Key Suppliers Lists

Table 132. Human Macrophage Colony Stimulating Factor Distributors List

Table 133. Human Macrophage Colony Stimulating Factor Customers List

Table 134. Human Macrophage Colony Stimulating Factor Market Trends

Table 135. Human Macrophage Colony Stimulating Factor Market Drivers

Table 136. Human Macrophage Colony Stimulating Factor Market Challenges

Table 137. Human Macrophage Colony Stimulating Factor Market Restraints

Table 138. Research Programs/Design for This Report

Table 139. Key Data Information from Secondary Sources

Table 140. Key Data Information from Primary Sources

Table 141. Authors List of This Report

List of Figures

Figure 1. Product Picture of Human Macrophage Colony Stimulating Factor

Figure 2. Global Human Macrophage Colony Stimulating Factor Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Human Macrophage Colony Stimulating Factor Market Share by Type: 2024 & 2031

Figure 4. Purity＞95% Product Picture

Figure 5. Purity≤95% Product Picture

Figure 6. Global Human Macrophage Colony Stimulating Factor Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Human Macrophage Colony Stimulating Factor Market Share by Application: 2024 & 2031

Figure 8. Medical and Biological Laboratories

Figure 9. University Laboratories

Figure 10. Others

Figure 11. Global Human Macrophage Colony Stimulating Factor Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Human Macrophage Colony Stimulating Factor Market Size (2020-2031) & (US$ Million)

Figure 13. Global Human Macrophage Colony Stimulating Factor Sales (2020-2031) & (K Units)

Figure 14. Global Human Macrophage Colony Stimulating Factor Average Price (US$/Unit) & (2020-2031)

Figure 15. Human Macrophage Colony Stimulating Factor Report Years Considered

Figure 16. Human Macrophage Colony Stimulating Factor Sales Share by Manufacturers in 2024

Figure 17. Global Human Macrophage Colony Stimulating Factor Revenue Share by Manufacturers in 2024

Figure 18. Global 5 and 10 Largest Human Macrophage Colony Stimulating Factor Players: Market Share by Revenue in Human Macrophage Colony Stimulating Factor in 2024

Figure 19. Human Macrophage Colony Stimulating Factor Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. Global Human Macrophage Colony Stimulating Factor Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 21. North America Human Macrophage Colony Stimulating Factor Sales Market Share by Country (2020-2031)

Figure 22. North America Human Macrophage Colony Stimulating Factor Revenue Market Share by Country (2020-2031)

Figure 23. United States Human Macrophage Colony Stimulating Factor Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Canada Human Macrophage Colony Stimulating Factor Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Europe Human Macrophage Colony Stimulating Factor Sales Market Share by Country (2020-2031)

Figure 26. Europe Human Macrophage Colony Stimulating Factor Revenue Market Share by Country (2020-2031)

Figure 27. Germany Human Macrophage Colony Stimulating Factor Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. France Human Macrophage Colony Stimulating Factor Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. U.K. Human Macrophage Colony Stimulating Factor Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Italy Human Macrophage Colony Stimulating Factor Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Russia Human Macrophage Colony Stimulating Factor Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Human Macrophage Colony Stimulating Factor Sales Market Share by Region (2020-2031)

Figure 33. Asia Pacific Human Macrophage Colony Stimulating Factor Revenue Market Share by Region (2020-2031)

Figure 34. China Human Macrophage Colony Stimulating Factor Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Japan Human Macrophage Colony Stimulating Factor Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. South Korea Human Macrophage Colony Stimulating Factor Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. India Human Macrophage Colony Stimulating Factor Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Australia Human Macrophage Colony Stimulating Factor Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. China Taiwan Human Macrophage Colony Stimulating Factor Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Southeast Asia Human Macrophage Colony Stimulating Factor Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Latin America Human Macrophage Colony Stimulating Factor Sales Market Share by Country (2020-2031)

Figure 42. Latin America Human Macrophage Colony Stimulating Factor Revenue Market Share by Country (2020-2031)

Figure 43. Mexico Human Macrophage Colony Stimulating Factor Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Brazil Human Macrophage Colony Stimulating Factor Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Argentina Human Macrophage Colony Stimulating Factor Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Colombia Human Macrophage Colony Stimulating Factor Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Middle East and Africa Human Macrophage Colony Stimulating Factor Sales Market Share by Country (2020-2031)

Figure 48. Middle East and Africa Human Macrophage Colony Stimulating Factor Revenue Market Share by Country (2020-2031)

Figure 49. Turkey Human Macrophage Colony Stimulating Factor Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Human Macrophage Colony Stimulating Factor Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. UAE Human Macrophage Colony Stimulating Factor Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Global Sales Market Share of Human Macrophage Colony Stimulating Factor by Type (2020-2031)

Figure 53. Global Revenue Market Share of Human Macrophage Colony Stimulating Factor by Type (2020-2031)

Figure 54. Global Human Macrophage Colony Stimulating Factor Price (US$/Unit) by Type (2020-2031)

Figure 55. Global Sales Market Share of Human Macrophage Colony Stimulating Factor by Application (2020-2031)

Figure 56. Global Revenue Market Share of Human Macrophage Colony Stimulating Factor by Application (2020-2031)

Figure 57. Global Human Macrophage Colony Stimulating Factor Price (US$/Unit) by Application (2020-2031)

Figure 58. Human Macrophage Colony Stimulating Factor Value Chain

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Macrophage Colony Stimulating Factor Reagent Market Research Report 2025

Global Recombinant Human M CSF Protein Market Research Report 2025

Global Recombinant Human Granulocyte Colony Stimulating Market Insights Forecast to 2030

Global Granulocyte Macrophage Colony Stimulating Factor GM CSF Market Research Report 2024

Granulocyte Colony Stimulating Factor G CSF Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Human Granulocyte Macrophage Colony stimulating Factor for Injection Market Research Report 2024

Global Human Granulocyte Colony Stimulating Factor for Injection Market Research Report 2024

Global Recombinant Human GM CSF for Injection Market Research Report 2024

Global Granulocyte Macrophage Colony Stimulating Factor GM CSF ELISA Kit Market Research Report 2024

Global Stem Cell Factor SCF Market Research Report 2024

Global Granulocyte Colony Stimulating Factor G CSF Market Research Report 2024

Global Long acting Granulocyte Colony Stimulating Factor G CSF Market Research Report 2024

Global Granulocyte Colony stimulating Factor G CSF ELISA Kit Market Research Report 2024

Global Cell Therapy Growth Factors Market Research Report 2024

Global Hematopoietic Stem Cells Storage and Consumables Market Research Report 2025

Global PEGylated Granulocyte Colony Stimulating Factor Market Research Report 2024

Hematopoietic Stem Cells Transplantation Market

Transplantation of Multipotent Hematopoietic Stem Cells Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Macrophage Anticancer Therapy Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions